Cirazoline

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QK318GVY3Y, chemically known as 1h-imidazole, 2-((2-cyclopropylphenoxy)methyl)-4,5-dihydro-, monohydrochloride but generally known as cirazoline, which bears US NIH Compound Identifier 2765. European Medicines Agency schedules Cirazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07478MIG. The term CIRAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). CIRAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cirazoline under HS 29332990 and SITC 51573. As of Q4 2014, CIRAZOLINE remains the US FDA Preferred Term for this commodity. Cirazoline bears US NLM identifiers UMLS ID C0109817 and NCI Concept Code C77294. SMILES: O(c1c(C2CC2)cccc1)CC1=NCCN1.